Aino‐Maija Leppä

机构：German Cancer Research Center, Heidelberg University, The Francis Crick Institute, CRUK Lung Cancer Centre of Excellence, DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Deutsches Konsortium für Translationale Krebsforschung, University College London · ORCID：0000-0003-0849-1759

发表论文 113 篇 · 总被引 684 次 · h-index 9

代表论文

• Plasma signals of lung tumor promotion for molecular cancer prevention (2026 · Cell · 被引 11)
• Evolutionary characterization of lung cancer metastasis (2026 · Nature · 被引 6)
• Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML (2026 · Cell stem cell · 被引 4)
• Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype (2026 · Blood · 被引 2)
• Clinical validity of ultrasensitive single-digit parts per million ctDNA detection in non–small cell lung cancer. (2026 · Journal of Clinical Oncology · 被引 1)
• Prospective clinical validation of MAC-scoring as an affordable, real-time biomarker for HMA/venetoclax response in AML (2025 · Blood · 被引 1)